We are live on ! Find out more
GNMK

GenMark Diagnostics, Inc
GNMK

Delisted

GNMK was delisted on the 21st of April, 2021.

Back to rankings

106 hedge funds and large institutions have $400M invested in GenMark Diagnostics, Inc in 2018 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 34 increasing their positions, 34 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more capital invested

Capital invested by funds: $355M → $400M (+$45.8M)

10% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 10

1% more funds holding

Funds holding: 105 → 106 (+1)

0% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 34

Holders
106
Holders Change
+1
Holders Change %
+0.95%
% of All Funds
2.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
34
Reduced
34
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Deutsche Bank
Deutsche Bank
Germany
+$1.93M
2
BlackRock
BlackRock
New York
+$1.84M
3
State Street
State Street
Massachusetts
+$1.4M
4
BG
Bellevue Group
Switzerland
+$1.12M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$842K

Top Sellers

Rank Fund Capital Flow
1
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$7.28M
2
CCM
Cadian Capital Management
New York
-$4.76M
3
PI
Putnam Investments
Massachusetts
-$1.52M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$1.47M
5
Morgan Stanley
Morgan Stanley
New York
-$1.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$63.6M -$1.47M -200,447 -2%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$61.5M +$375K +51,098 +0.6%
JP Morgan Chase
3
JP Morgan Chase
New York
$32.4M +$265K +36,100 +0.8%
CCM
4
Cadian Capital Management
New York
$28.2M -$4.76M -649,216 -14%
BlackRock
5
BlackRock
New York
$26.5M +$1.84M +251,078 +7%
CC
6
Casdin Capital
New York
$25.7M +$734K +100,000 +3%
PI
7
Putnam Investments
Massachusetts
$25.7M -$1.52M -207,036 -6%
Vanguard Group
8
Vanguard Group
Pennsylvania
$19.2M +$256K +34,940 +1%
HighTower Advisors
9
HighTower Advisors
Illinois
$17.2M +$157K +21,385 +0.9%
BG
10
Bellevue Group
Switzerland
$9.85M +$1.12M +153,000 +13%
State Street
11
State Street
Massachusetts
$9.61M +$1.4M +191,402 +17%
Bank of America
12
Bank of America
North Carolina
$7.3M +$616K +83,908 +9%
Morgan Stanley
13
Morgan Stanley
New York
$5.13M -$1.2M -164,192 -19%
Northern Trust
14
Northern Trust
Illinois
$5M +$128K +17,488 +3%
Millennium Management
15
Millennium Management
New York
$4.64M -$809K -110,308 -15%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$4.15M +$230K +31,402 +6%
Thrivent Financial for Lutherans
17
Thrivent Financial for Lutherans
Minnesota
$3.94M -$474K -64,543 -11%
PCM
18
Penn Capital Management
Pennsylvania
$3.35M -$95 -13 -0%
Alyeska Investment Group
19
Alyeska Investment Group
Illinois
$2.88M -$7.28M -991,919 -72%
SSA
20
Schonfeld Strategic Advisors
New York
$2.76M +$729K +99,300 +36%
Deutsche Bank
21
Deutsche Bank
Germany
$2.7M +$1.93M +263,312 +253%
D.E. Shaw & Co
22
D.E. Shaw & Co
New York
$2.52M +$842K +114,693 +50%
PWP
23
Private Wealth Partners
California
$2.21M -$514K -70,000 -19%
Charles Schwab
24
Charles Schwab
California
$2.2M +$178K +24,292 +9%
NIM
25
Needham Investment Management
New York
$1.91M +$220K +30,000 +13%
1
2 3 4 5

GNMK Hedge Fund Activity: Q3 2018 in Review

106 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q3 2018, worth a combined $400M — up 13% from $355M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new GNMK positions and 10 closed out — a net gain of 1 holder — while 34 added to existing stakes and 34 trimmed.

The largest buyer was Deutsche Bank, adding an estimated $1.93M. The largest seller was Alyeska Investment Group, cutting an estimated $7.28M.

  • 106 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q3 2018, up from 105 in Q2 2018.
  • Funds reported $400M of GenMark Diagnostics, Inc stock for Q3 2018, up 13% quarter-over-quarter.
  • 11 funds opened new GenMark Diagnostics, Inc positions in Q3 2018 and 10 closed out, a net change of +1 holder.
  • The largest GenMark Diagnostics, Inc buyer in Q3 2018 was Deutsche Bank, an estimated $1.93M added.
  • The largest GenMark Diagnostics, Inc seller in Q3 2018 was Alyeska Investment Group, an estimated $7.28M sold.

Based on aggregated 13F filings for Q3 2018.